Why AbbVie's Booming 2017 Could Continue in 2018 Post author:Sam Post published:December 14, 2017 Post category:BioPharma Now that 2017 is drawing to an end, though, it’s time to focus on the new year. Source: BioSpace You Might Also Like Cyteir Therapeutics Nabs $29 Million and a New CEO March 7, 2018 New Immuno-Onco Deal With Merck KGaA Could Make This UK Biotech a $1 Billion Company June 4, 2017 FDA Orders 6 Partial or Full Clinical Holds on Celgene's Blood Cancer Studies September 6, 2017
